CLRT: CLARIENT INC Real-Time Headlines

Ticker

Advertisement

Choose a Broker

Dynamic view of the market

U.S. Markets open in 11 hrs, 20 mins

Symbol	Value	Change	Percentage Change
DJIA	10,023.42	17.46	0.17%
NASDAQ	2,112.44	7.12	0.34%
S&P 500	1,069.30	2.67	0.25%

Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Learn More

Get the FREE DailyFinance iPhone application

CLARIENT INC

CLRT

Stock price

2.58 0.15 6.17%

as of 04:00 PM EST on 11/06/2009 in USD (NASDAQ Delay: 15 mins.)
Extended Hours

2.4972 -0.0828 -3.21%

as of 04:10 PM EST on 11/06/09

Analyst Consensus

Buy
Analyst Consensus

Strong Buy

Buy

Hold

Sell

Strong Sell
- Add to Portfolio
- Add to Alerts

CLARIENT INC Real-Time Headlines

Customize
Thursday, November 5, 2009

SEC Filing: Insider Buy/Sell

11/5/09 View all Related Articles > | Thomson Financial

Wednesday, November 4, 2009

On The Fly: U.S. Market Wrap-Up for Wednesday 11/4

11/4/09 | Theflyonthewall.com

Safeguard Scientifics, Inc. Q3 2009 Earnings Call Transcript

11/4/09 | Seeking Alpha

Ambac, Mod-Pac: Midday Volume Plays

11/4/09 | TheStreet.com

Safeguard Scientifics Announces Third Quarter 2009 Financial Results

11/4/09 | Business Wire

Tuesday, November 3, 2009

Clarient (CLRT) Misses Q3 EPS by 5c; Guides Lower for FY Revenues - Below Consensus

11/3/09 | StreetInsider.com

Clarient lowers 2009 sales guidance to $90M-$94M from $96M-$101M

11/3/09 | Theflyonthewall.com

Clarient reports Q3 EPS (4c) vs. consensus of 1c

11/3/09 | Theflyonthewall.com

Thursday, October 29, 2009

Clarient to Release 2009 Third Quarter Financial Results on Tuesday, November 3rd

10/29/09 View all Related Articles > | StockHouse

Clarient to Release 2009 Third Quarter Financial Results on Tuesday, November 3rd

10/29/09 | GlobeNewswire

Wednesday, October 14, 2009

Zacks #5 Rank Additions for Wednesday - Zacks Tale of the Tape

10/14/09 | Zacks Investment Research

Tuesday, October 13, 2009

Results Reveal Oncotype DX Utility - Analyst Blog

10/13/09 | Zacks Investment Research

Friday, October 9, 2009

SEC Filing: Current Event

10/9/09 View all Related Articles > | Thomson Financial

Tuesday, October 6, 2009

Zacks #5 Rank Additions for Tuesday - Zacks Tale of the Tape

10/6/09 | Zacks Investment Research

Tuesday, September 29, 2009

Clarient to Present at William Blair Third Annual Emerging Growth Conference in New York City

9/29/09 | PR Newswire

Monday, September 28, 2009

SEC Filing: Current Event

9/28/09 | Thomson Financial

Tuesday, September 22, 2009

SEC Filing: Current Event

9/22/09 | Thomson Financial

Safeguard Sells Clarient Shares

9/22/09 View all Related Articles > | ABC News

Safeguard Scientifics Announces Sale of 2.4 Million Additional Clarient Shares Pursuant to Overallotment Option

9/22/09 | Business Wire

Friday, September 18, 2009

SEC Filing: Acquisition Statement

9/18/09 View all Related Articles > | Thomson Financial

Friday, September 4, 2009

SEC Filing: Insider Buy/Sell

9/4/09 View all Related Articles > | Thomson Financial

Good News for Genomic Health - Analyst Blog

9/4/09 | Zacks Investment Research

Tuesday, September 1, 2009

Clarient to Present at Upcoming Investment Conferences in New York City

9/1/09 | PR Newswire

Friday, August 28, 2009

SEC Filing: Current Event

8/28/09 View all Related Articles > | Thomson Financial

Thursday, August 27, 2009

Safeguard Scientifics sells part of Clarient stake

8/27/09 View all Related Articles > | Philadelphia Business Journal - Philadelphia PA

Safeguard Scientifics (SFE) Announces Sale of Approximately One-Third of Its Clarient (CLRT) Shares for Approximately $53 Million in Proceeds

8/27/09 View all Related Articles > | StreetInsider.com

Safeguard Scientifics Announces Sale of Approximately One-Third of Its Clarient Shares for Approximately $53 Million in Proceeds, Net of Underwriter Commissions

8/27/09 | Business Wire

Friday, August 21, 2009

5 Cold Stocks Heating Up

8/21/09 | The Motley Fool

SEC Filing: All Registrations

8/21/09 | Thomson Financial

Tuesday, August 11, 2009

SEC Filing: Current Event

8/11/09 View all Related Articles > | Thomson Financial

Wednesday, August 5, 2009

Safeguard brings in $146 million profit

8/5/09 View all Related Articles > | Philadelphia Business Journal - Philadelphia PA

Safeguard Scientifics Announces Second Quarter 2009 Financial Results

8/5/09 | Business Wire

Clarient to Present at Canaccord Adams 29th Annual Global Growth Conference on Wednesday, August 12th

8/5/09 | PR Newswire

Tuesday, August 4, 2009

Clarient (CLRT) Misses Q2 EPS by 6c

8/4/09 View all Related Articles > | StreetInsider.com

SEC Filing: Current Event

8/4/09 View all Related Articles > | Thomson Financial

Clarient Reports Second Quarter Revenue Up 40 Percent

8/4/09 | PR Newswire

Friday, July 31, 2009

SEC Filing: Insider Buy/Sell

7/31/09 | Thomson Financial

Tuesday, July 28, 2009

Clarient to Release 2009 Second Quarter Financial Results On Tuesday, August 4th

7/28/09 | GlobeNewswire

Wednesday, July 22, 2009

Emerging Growth Equities, Ltd. Initiates Coverage of Clarient, Inc. With a Buy Rating and $4.50 Price Target

7/22/09 View all Related Articles > | TradingMarkets

Emerging Growth Equities, Ltd. Initiates Coverage of Clarient, Inc. With a Buy Rating and $4.50 Price Target

7/22/09 | PR Newswire

1 <Next>
Thursday, November 5, 2009

SEC Filing: Insider Buy/Sell

11/5/09 View all News Related Articles > | Thomson Financial

Wednesday, November 4, 2009

On The Fly: U.S. Market Wrap-Up for Wednesday 11/4

11/4/09 | Theflyonthewall.com

Ambac, Mod-Pac: Midday Volume Plays

11/4/09 | TheStreet.com

Tuesday, November 3, 2009

Clarient lowers 2009 sales guidance to $90M-$94M from $96M-$101M

11/3/09 | Theflyonthewall.com

Clarient reports Q3 EPS (4c) vs. consensus of 1c

11/3/09 | Theflyonthewall.com

Thursday, October 29, 2009

Clarient to Release 2009 Third Quarter Financial Results on Tuesday, November 3rd

10/29/09 | StockHouse

Wednesday, October 14, 2009

Zacks #5 Rank Additions for Wednesday - Zacks Tale of the Tape

10/14/09 | Zacks Investment Research

Tuesday, October 13, 2009

Results Reveal Oncotype DX Utility - Analyst Blog

10/13/09 | Zacks Investment Research

Friday, October 9, 2009

SEC Filing: Current Event

10/9/09 View all News Related Articles > | Thomson Financial

Tuesday, October 6, 2009

Zacks #5 Rank Additions for Tuesday - Zacks Tale of the Tape

10/6/09 | Zacks Investment Research

Monday, September 28, 2009

SEC Filing: Current Event

9/28/09 | Thomson Financial

Tuesday, September 22, 2009

SEC Filing: Current Event

9/22/09 | Thomson Financial

Safeguard sells Clarient shares

9/22/09 View all News Related Articles > | U.S. News & World Report

Friday, September 18, 2009

SEC Filing: Acquisition Statement

9/18/09 View all News Related Articles > | Thomson Financial

Friday, September 4, 2009

SEC Filing: Insider Buy/Sell

9/4/09 View all News Related Articles > | Thomson Financial

Good News for Genomic Health - Analyst Blog

9/4/09 | Zacks Investment Research

Friday, August 28, 2009

SEC Filing: Current Event

8/28/09 View all News Related Articles > | Thomson Financial

Friday, August 21, 2009

5 Cold Stocks Heating Up

8/21/09 | The Motley Fool

SEC Filing: All Registrations

8/21/09 | Thomson Financial

Tuesday, August 11, 2009

SEC Filing: Current Event

8/11/09 View all News Related Articles > | Thomson Financial

Wednesday, August 5, 2009

Safeguard Scientifics Announces Second Quarter 2009 Financial Results

8/5/09 | TradingMarkets

Tuesday, August 4, 2009

SEC Filing: Current Event

8/4/09 View all News Related Articles > | Thomson Financial

Clarient Reports Second Quarter Revenue Up 40 Percent

8/4/09 | TradingMarkets

Friday, July 31, 2009

SEC Filing: Insider Buy/Sell

7/31/09 | Thomson Financial

Wednesday, July 22, 2009

Emerging Growth Equities, Ltd. Initiates Coverage of Clarient, Inc. With a Buy Rating and $4.50 Price Target

7/22/09 | TradingMarkets

Monday, July 20, 2009

SEC Filing: Current Event

7/20/09 | Thomson Financial

Tuesday, July 14, 2009

Health Discovery Corporation Announces Publication of Peer Reviewed Scientific Paper Demonstrating the Clinical Validity of the Four-Gene Prostate Cancer Test Licensed to Abbott, Quest Diagnostics and Clarient

7/14/09 | TradingMarkets

Monday, July 13, 2009

SEC Filing: Certain Transactions

7/13/09 View all News Related Articles > | Thomson Financial

Wednesday, July 8, 2009

SEC Filing: Employee benefit Plans

7/8/09 | Thomson Financial

Monday, June 29, 2009

Clarient Set to Join Russell 3000 Index

6/29/09 | TradingMarkets

Monday, June 22, 2009

5 Stocks That Just Won't Quit

6/22/09 | The Motley Fool

Safeguard Scientifics Portfolio Company Clarient Files Form S-3 Registration Statement

6/22/09 | TradingMarkets

SEC Filing: Certain Transactions

6/22/09 View all News Related Articles > | Thomson Financial

Wednesday, June 17, 2009

SEC Filing: Annual Financials

6/17/09 | Thomson Financial

Tuesday, June 16, 2009

Clarient Steering Ahead - Launches Gene Mutation Test For Selecting Lung Cancer Therapy

6/16/09 | RTTNews

Wednesday, June 3, 2009

Clarient to Present at Noble Financial's 5th Annual Equity Conference on Tuesday, June 9th

6/3/09 | The Pink Sheet Daily

Tuesday, May 26, 2009

Safeguard Scientifics to Recognize an Unrealized Gain of Approximately $120 Million upon Deconsolidation of Its Ownership in Clarient

5/26/09 View all News Related Articles > | TradingMarkets

Tuesday, May 19, 2009

PennyStockChaser.com: Safeguard Scientifics, Inc. (NYSE:SFE) Hot Stock on the Move!

5/19/09 | TradingMarkets

Monday, May 18, 2009

SEC Filing: Current Event

5/18/09 View all News Related Articles > | Thomson Financial

Safeguard Scientifics' Portfolio Company, Clarient, Inc., Completes Second Tranche of Private Placement with Oak Investment Partners

5/18/09 View all News Related Articles > | TradingMarkets

1 <Next>
Thursday, August 27, 2009

Safeguard Scientifics Announces Sale of Approximately One-Third of Its Clarient Shares for Approximately $53 Million

8/27/09 | PR-inside - Austria

Wednesday, August 5, 2009

Safeguard Scientifics Announces Second Quarter 2009 Financial Results

8/5/09 View all Trade Related Articles > | StockWatch

Tuesday, August 4, 2009

Clarient Reports Second Quarter Revenue Up 40 Percent

8/4/09 | StockWatch

Wednesday, July 22, 2009

Emerging Growth Equities, Ltd. Initiates Coverage of Clarient, Inc. With a Buy Rating and $4.50 Price Target

7/22/09 | StockWatch

Monday, June 29, 2009

Clarient Set to Join Russell 3000 Index

6/29/09 | StockWatch

Monday, June 22, 2009

Safeguard Scientifics Portfolio Company Clarient Files Form S-3 Registration Statement

6/22/09 View all Trade Related Articles > | StockWatch

Wednesday, June 17, 2009

Clarient Launches New Gene Mutation Test

6/17/09 | Pharmaceutical Business Review Online - UK

Wednesday, June 3, 2009

Clarient to Present at Noble Financial's 5th Annual Equity Conference on Tuesday, June 9th

6/3/09 View all Trade Related Articles > | The Pink Sheet Daily

Tuesday, May 26, 2009

Safeguard Scientifics to Recognize an Unrealized Gain of Approximately $120 Million upon Deconsolidation of Its

5/26/09 | PR-inside - Austria

Monday, May 18, 2009

Safeguard Scientifics’ Portfolio Company, Clarient, Inc., Completes Second Tranche of Private Placement with Oak Investment

5/18/09 View all Trade Related Articles > | PR-inside - Austria

Friday, May 8, 2009

Clarient introduces new breast cancer test

5/8/09 | Pharmaceutical Business Review Online - UK

Wednesday, May 6, 2009

Clarient Reports 41% Revenue Increase for First Quarter 2009

5/6/09 View all Trade Related Articles > | The Pink Sheet Daily

Tuesday, May 5, 2009

Clarient Launches New Breast Cancer Test

5/5/09 View all Trade Related Articles > | The Pink Sheet Daily

Thursday, April 23, 2009

Clarient Granted Exclusive License to Commercialize Breast Cancer Biomarker by Indiana University Research and Technology Corporation

4/23/09 | The Pink Sheet Daily

Thursday, March 26, 2009

Clarient Entered Into Private Placement of Up To $50 Million in Convertible Preferred Stock With Oak Investment Partners

3/26/09 View all Trade Related Articles > | The Pink Sheet Daily

Thursday, March 12, 2009

Clarient to Present at the Cowen and Company 29th Annual Health Care Conference on Tuesday, March 17th

3/12/09 View all Trade Related Articles > | PharmaLive

Wednesday, March 11, 2009

Clarient Reports Strong Revenue Increase for Fourth Quarter and Full-Year 2008

3/11/09 View all Trade Related Articles > | The Pink Sheet Daily

Wednesday, March 4, 2009

Clarient Reschedules Fourth Quarter and Year-End 2008 Financial Results Release To Wednesday, March 11th; Conference Call and Webcast Rescheduled For 5:00 PM EDT That Day

3/4/09 View all Trade Related Articles > | StockWatch

Tuesday, March 3, 2009

Clarient Renews and Expands Mezzanine Credit Facility With Safeguard

3/3/09 View all Trade Related Articles > | StockWatch

Wednesday, February 11, 2009

Clarient to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference on Wednesday, February 18th

2/11/09 View all Trade Related Articles > | StockWatch

Monday, February 2, 2009

Clarient Extends Maturities of $20 Million in Existing Credit Facilities

2/2/09 | PR-inside - Austria

Friday, January 16, 2009

Clarient launches new prostate cancer test

1/16/09 | Datamonitor

Thursday, January 15, 2009

Clarient Launches Gene Expression Test For Prostate Cancer

1/15/09 View all Trade Related Articles > | MediLexicon

Tuesday, January 13, 2009

Clarient Launches Gene Expression Test for Prostate Cancer

1/13/09 View all Trade Related Articles > | StockWatch

Thursday, December 11, 2008

Clarient's Insight Dx Breast Cancer Profile Validated by New Data

12/11/08 View all Trade Related Articles > | Genetic Engineering News

Tuesday, December 2, 2008

Clarient Introduces Second Gene Mutation Test for Colorectal Cancer

12/2/08 View all Trade Related Articles > | StockWatch

Monday, November 3, 2008

Clarient, Inc. to Present at the Rodman & Renshaw Healthcare Conference on November 12

11/3/08 | PharmaInfo.net - Canada

Thursday, October 16, 2008

Clarient to Release Third Quarter 2008 Financial Results on Wednesday, October 29

10/16/08 | PharmaLive

Thursday, October 2, 2008

[video] Ronald Andrews, CEO of Clarient, Inc. Discusses Agreement With University of Pennsylvania School of Medicine on WallSt.net's 3-Minute Press Show

10/2/08 | The Pink Sheet Daily

Monday, September 29, 2008

Clarient signs training and consulting agreement with Flow Cytometry Lab

9/29/08 | Datamonitor

Clarient Enters into Training and Consulting Agreement with University of Pennsylvania School of Medicine

9/29/08 View all Trade Related Articles > | StockWatch

Friday, September 26, 2008

Clarient and Definiens form partnership

9/26/08 | Datamonitor

Thursday, September 25, 2008

Clarient Allys with Definiens for Image Analysis Tools for Use in Cancer Diagnostics

9/25/08 | Genetic Engineering News

Wednesday, September 3, 2008

Clarient to Present at the Baird Small Cap Health Care Conference on September 10

9/3/08 View all Trade Related Articles > | StockWatch

Thursday, August 7, 2008

Clarient and Health Discovery complete validation studies for cancer test

8/7/08 View all Trade Related Articles > | Datamonitor

Wednesday, July 2, 2008

Clarient introduces new colorectal cancer test

7/2/08 | Datamonitor

Tuesday, July 1, 2008

Clarient Launches New Colorectal Cancer Test

7/1/08 | The Pink Sheet Daily

Thursday, June 26, 2008

Clarient Reports Positive Data From Phase I, II Clinical Validation Of Gene-Based Molecular Diagnostic Test For Prostate Cancer

6/26/08 | Biocompare

Wednesday, June 11, 2008

Form 4 CLARIENT, INC For: Jun 10 Filed by: SAFEGUARD SCIENTIFICS INC

6/11/08 | smallcapcenter.com

Friday, May 30, 2008

Clarient names new senior vice president and CFO

5/30/08 View all Trade Related Articles > | Datamonitor

1 <Next>
Tuesday, September 22, 2009

Safeguard Sells Clarient Shares

9/22/09 View all Regional Related Articles > | ABC News

Thursday, August 27, 2009

Safeguard Scientifics sells part of Clarient stake

8/27/09 View all Regional Related Articles > | Philadelphia Business Journal - Philadelphia PA

Wednesday, August 5, 2009

Safeguard brings in $146 million profit

8/5/09 | Philadelphia Business Journal - Philadelphia PA

Monday, June 22, 2009

Safeguard Scientifics sticking with Clarient stock strategy

6/22/09 | Philadelphia Business Journal - Philadelphia PA

Wednesday, May 27, 2009

Safeguard Scientifics expecting income boost from Clarient deal

5/27/09 | Philadelphia Business Journal - Philadelphia PA

Tuesday, May 19, 2009

Cancer Testing Company Clarient Pays Off Debt

5/19/09 | Orange County Business Journal

Monday, May 18, 2009

Stock deal at portfolio firm frees up cash for Safeguard Scientifics

5/18/09 | Philadelphia Business Journal - Philadelphia PA

Thursday, April 23, 2009

California Company Lands Rights For IURTC Biomarker

4/23/09 | Inside Indiana Business - Indianapolis IN

Thursday, October 4, 2007

Clarient hires Michael J. Pellini as chief operating officer; 2 executives resign

10/4/07 View all Regional Related Articles > | CBS - CBS 11 - Dallas / Fort Worth TX

1
Wednesday, November 4, 2009

Safeguard Scientifics Announces Third Quarter 2009 Financial Results

11/4/09 | Business Wire

Thursday, October 29, 2009

Clarient to Release 2009 Third Quarter Financial Results on Tuesday, November 3rd

10/29/09 | GlobeNewswire

Tuesday, September 29, 2009

Clarient to Present at William Blair Third Annual Emerging Growth Conference in New York City

9/29/09 | PR Newswire

Tuesday, September 22, 2009

Safeguard Scientifics Announces Sale of 2.4 Million Additional Clarient Shares Pursuant to Overallotment Option

9/22/09 | Business Wire

Tuesday, September 1, 2009

Clarient to Present at Upcoming Investment Conferences in New York City

9/1/09 | PR Newswire

Thursday, August 27, 2009

Safeguard Scientifics Announces Sale of Approximately One-Third of Its Clarient Shares for Approximately $53 Million in Proceeds, Net of Underwriter Commissions

8/27/09 | Business Wire

Wednesday, August 5, 2009

Safeguard Scientifics Announces Second Quarter 2009 Financial Results

8/5/09 | Business Wire

Clarient to Present at Canaccord Adams 29th Annual Global Growth Conference on Wednesday, August 12th

8/5/09 | PR Newswire

Tuesday, August 4, 2009

Clarient Reports Second Quarter Revenue Up 40 Percent

8/4/09 | PR Newswire

Tuesday, July 28, 2009

Clarient to Release 2009 Second Quarter Financial Results On Tuesday, August 4th

7/28/09 | GlobeNewswire

Wednesday, July 22, 2009

Emerging Growth Equities, Ltd. Initiates Coverage of Clarient, Inc. With a Buy Rating and $4.50 Price Target

7/22/09 | PR Newswire

Tuesday, July 14, 2009

Health Discovery Corporation Announces Publication of Peer Reviewed Scientific Paper Demonstrating the Clinical Validity of the Four-Gene Prostate Cancer Test Licensed to Abbott, Quest Diagnostics and Clarient

7/14/09 | Business Wire

Monday, June 29, 2009

Clarient Set to Join Russell 3000 Index

6/29/09 | PR Newswire

Monday, June 22, 2009

Safeguard Scientifics Portfolio Company Clarient Files Form S-3 Registration Statement

6/22/09 | Business Wire

Tuesday, June 16, 2009

Clarient Launches New Gene Mutation Test to Help Select Therapy for Non-Small Cell Lung Cancer

6/16/09 | PR Newswire

Wednesday, June 3, 2009

Clarient to Present at Noble Financial's 5th Annual Equity Conference on Tuesday, June 9th

6/3/09 | PR Newswire

Tuesday, May 26, 2009

Safeguard Scientifics to Recognize an Unrealized Gain of Approximately $120 Million upon Deconsolidation of Its Ownership in Clarient

5/26/09 | Business Wire

Monday, May 18, 2009

Safeguard Scientifics’ Portfolio Company, Clarient, Inc., Completes Second Tranche of Private Placement with Oak Investment Partners

5/18/09 | Business Wire

Thursday, May 7, 2009

Safeguard Scientifics Announces First Quarter 2009 Financial Results

5/7/09 | Business Wire

Wednesday, May 6, 2009

Clarient Reports 41% Revenue Increase for First Quarter 2009

5/6/09 | PR Newswire

Tuesday, May 5, 2009

Clarient Launches New Breast Cancer Test

5/5/09 | PR Newswire

Friday, May 1, 2009

Clarient to Release First Quarter 2009 Financial Results On Wednesday, May 6th

5/1/09 | GlobeNewswire

Thursday, April 23, 2009

Clarient Granted Exclusive License to Commercialize Breast Cancer Biomarker by Indiana University Research and Technology Corporation

4/23/09 | PR Newswire

Live Updates:

Ticker

Dynamic view of the market

CLARIENT INC

CLRT

Stock price

Extended Hours

CLARIENT INC Real-Time Headlines

Thursday, November 5, 2009

Wednesday, November 4, 2009

Tuesday, November 3, 2009

Thursday, October 29, 2009

Wednesday, October 14, 2009

Tuesday, October 13, 2009

Friday, October 9, 2009

Tuesday, October 6, 2009

Tuesday, September 29, 2009

Monday, September 28, 2009

Tuesday, September 22, 2009

Friday, September 18, 2009

Friday, September 4, 2009

Tuesday, September 1, 2009

Friday, August 28, 2009

Thursday, August 27, 2009

Friday, August 21, 2009

Tuesday, August 11, 2009

Wednesday, August 5, 2009

Tuesday, August 4, 2009

Friday, July 31, 2009

Tuesday, July 28, 2009

Wednesday, July 22, 2009

Thursday, November 5, 2009

Wednesday, November 4, 2009

Tuesday, November 3, 2009

Thursday, October 29, 2009

Wednesday, October 14, 2009

Tuesday, October 13, 2009

Friday, October 9, 2009

Tuesday, October 6, 2009

Monday, September 28, 2009

Tuesday, September 22, 2009

Friday, September 18, 2009

Friday, September 4, 2009

Friday, August 28, 2009

Friday, August 21, 2009

Tuesday, August 11, 2009

Wednesday, August 5, 2009

Tuesday, August 4, 2009

Friday, July 31, 2009

Wednesday, July 22, 2009

Monday, July 20, 2009

Tuesday, July 14, 2009

Monday, July 13, 2009

Wednesday, July 8, 2009

Monday, June 29, 2009

Monday, June 22, 2009

Wednesday, June 17, 2009

Tuesday, June 16, 2009

Wednesday, June 3, 2009

Tuesday, May 26, 2009

Tuesday, May 19, 2009

Monday, May 18, 2009

Thursday, August 27, 2009

Wednesday, August 5, 2009

Tuesday, August 4, 2009

Wednesday, July 22, 2009